Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology

5893 - The role of primary tumour location in the recurrence rate of metachronous metastasis of colon cancer

Date

21 Oct 2018

Session

Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology

Topics

Cancer Prevention

Tumour Site

Colon and Rectal Cancer

Presenters

Margherita Rimini

Citation

Annals of Oncology (2018) 29 (suppl_8): viii150-viii204. 10.1093/annonc/mdy281

Authors

M. Rimini1, C. Bardasi2, F. Gelsomino3, K. Andrikou3, C. Santini4, G. Orsi5, M. Salati6, M.L. Riggi5, S. Pipitone7, S. Cascinu8, A. Spallanzani9

Author affiliations

  • 1 Modena Cancer Center, Department Of Oncology/hematology, University Of Modena, Azienda Ospedaliero - Universitaria Policlinico di Modena, 41125 - Modena/IT
  • 2 Modena Cancer Center, Department Of Oncology/hematology,, University of Modena and Reggio Emilia, 41125 - Modena/IT
  • 3 Medical Oncology, University Hospital of Modena, 41100 - Modena/IT
  • 4 Modena Cancer Center, Department Of Oncology/hematology, University of Modena and Reggio Emilia, 41125 - Modena/IT
  • 5 Department Of Oncology/hematology, University Of Modena And Reggio Emilia, Modena Cancer Center,, 41124 - modena/IT
  • 6 Modena Cancer Center, Department Of Oncology/hematology, Azienda Ospedaliero - Universitaria Policlinico di Modena, 41100 - Modena/IT
  • 7 Dipartimento Di Oncologia Ed Ematologia, Azienda Ospedaliero - Universitaria Policlinico di Modena, 41125 - Modena/IT
  • 8 Oncology, Azienda Ospedaliero - Universitaria Policlinico di Modena, 41100 - Modena/IT
  • 9 Medical Oncology, University Hospital of Modena, Modena/IT

Resources

Login to access the resources on OncologyPRO.

If you do not have an ESMO account, please create one for free.

Abstract 5893

Background

Recent studies suggest that primary tumour location (PTL) has a prognostic value in patients (pts) with metastatic colorectal cancer (CRC), while its role in early stage disease remains unclear. The aim of this analysis is to investigate the relationship between PTL and the development of metachronous metastasis.

Methods

We performed a population-based study from Modena Cancer Registry collecting data of patients (pts) with early stage disease (stage I, II, III) who underwent surgery from 1995 to 2010. We hypothesized a potential impact of PTL on the postoperative recurrence rate. Fisher’s exact test, univariate and multivariate Cox regression analysis were performed.

Results

During the study period, 1570 pts with left-sided colon cancer (LCC) and 841 pts with right-sided colon cancer (RCC) were registered. In the entire cohort, 268 of 1576 pts (17%) with LCC and 100 of 841 pts (11.2 %) with RCC developed metachronous metastasis, for a total of 368 of 2411 pts (15%). Comparing LCC and RCC clinical and pathological status we found no statistically difference in lymph-node status (p = 0.737) but an increasing rate of G3 cancers in RCC vs LCC (p = 0.010). Median overall survival (OS) from early stage disease diagnosis for LCC patients was 45 months versus 35 months for RCC patients, with no significant difference in relapse free survival between the two groups (23.8 Vs 23.0 months). When relapsed, time to death resulted to be significantly longer in LCC group than in RCC group (14.7 vs 6.3 months; HR 1.46, 95% C.I. 1,16-1,86; p 0,001). In the multivariate Cox regression analysis adjusted for grading and stage at diagnosis, we confirmed a statistically significant impact of the primary tumour sidedness on OS in the relapsed setting (HR 1.48, 95% C.I: 1.15-1.89, p = 0.001).

Conclusions

In accordance to literature, our registry data confirm the prognostic role of PTL in advanced colorectal cancers: in particular, right-sided tumours have low recurrence rate but poor prognosis once relapsed. Other investigations are necessary to better understand the substantial heterogeneity within the molecular biology of RCC and LCC in order to provide a better post-operative surveillance and to select the most effective treatment strategies after relapse.

Clinical trial identification

Legal entity responsible for the study

Modena University Hospital.

Funding

Has not received any funding.

Editorial Acknowledgement

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.